New York Times
"The mRNA platform used in the Pfizer and Moderna vaccines can be readily tweaked, enabling the companies to produce newer versions within weeks. Moderna began modifying its vaccine to combat the variant identified in South Africa, after reports emerged that the existing vaccines are slightly less effective against that variant."
I am happy to sign up for these Moderna service packs.
« Previous post / Next post »
Hi! You're reading a single post on a weblog by Paul Bausch where I share recommended links, my photos, and occasional thoughts.